Health ❯ Biotechnology

Gene Therapy

Aging Therapeutics Development Hemophilia Anti-Aging FDA Approval Regulatory Approval Cancer Treatments Duchenne Muscular Dystrophy

Life Biosciences Doses First Patient With Eye Reprogramming Gene Therapy

The study uses a doxycycline-controlled three-gene system to treat glaucoma with a reversible safety switch to limit gene activity.

Johnson & Johnson to Build $1 Billion Cell Therapy Plant in Pennsylvania

FDA Flags Possible License Revocation for Sarepta’s Elevidys